PA72 Expression of transforming growth factors and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondrocytes  by unknown
$42 
Conclusions: These findings suggest that the alteration of com- 
plex II activity may contribute to pathological process in OA. NO 
is involved in pathological development of OA because it modi- 
fies the mitochondrial respiratory activity and induces a mito- 
chondril depolarization. 
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Aim: The aim of this study was to investigate the effects of TGF- 
and TNF-c~ on expression of CTGF by normal canine articular 
chondrocytes maintained in alginate culture. 
Methods: Cartilage was obtained post-mortem from normal 
canine stifle joints. Chondrocytes were isolated by collagenase 
digestion, cultured to second passage in monolayer and trans- 
ferred to alginate. Alginate embedded chondrocytes were stimu- 
lated with a range of doses of TGFb (0.2 - 25nglml) and TNF-c~ (2 
- 250ng/ml), either singly or in combination for 24 hours. Canine 
specific CTGF primers were used in RT-PCR to examine mRNA 
expression. 
Results: CTGF mRNA was constitutively expressed by canine 
chondrocytes and was significantly upregulated by TGF-I~, while 
TNF-c~ caused a significant decrease. Changes were found to be 
dose-dependant and costimulation showed an antagonistic rela- 
tionship between the two cytokines. 
Conclusion: We showed CTGF mRNA to be expressed by nor- 
mal canine articular chondrocytes and that its expression can be 
modulated by both the anabolic growth factor TGF-~ and the 
catabolic cytokine TNF-(z. While both TGF-~ and TNF-a have 
been shown to modulate CTGF expression in fibroblasts, there is 
no published data on its regulation in articular chondrocytes. As 
a downstream effector of TGF-J3 action CTGF offers a potential 
therapeutic target in OA as increased expression could both stim- 
ulate ECM component production and inhibit catabolic enzyme 
synthesis. 
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SUSCEPTIBILITY OF OA CARTILAGE TO THE EFFECTS OF 
IL-lb ARE NOT RELATED TO EXPRESSION OF EITHER THE 
TYPE I OR TYPE II |L-1B RECEPTOR 
Srinivasan MS, Elson CJ 
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Introduction: Whether IL-I~ contributes to the focal loss of car- 
tilage characteristic of osteoarthritis (OA) is not clear. The sus- 
ceptibility of cartilage from different regions of OA knee joints to 
the effects of IL-I and its relationship with chondrocyte xpres- 
sion of type I, signaling, and type II, decoy, IL-113 receptors (R) 
was therefore xamined. 
Methods: Cartilage was obtained from different regions on the 
knees of II OA patients undergoing surgery for total knee replace- 
ment (1) and incubated for 14 days with IL-I~ (2Opg/ml). 
Chondrocytes were isolated by enzymatic digestion from carti- 
lage off-cuts obtained from each region (1). Chondrocytes and 
HEL92 ceils, used as a positive control for IL-1 R, were stained 
with non-crossreacting antibodies to type 1 or type II IL-1R 
(Genzyine) and II.-1 R expression determined by flow cytometry. 
Results: Significant regional variation was observed in suscepti- 
bility to the effects of IL-1. Differences were apparent in chon- 
drocyte expression of the two receptor types; IL-1RI and IL-1RII 
expression was related. 
Table L IL-JR expression on chondrocytes isolated from OA car- 
tilage 
Expression IL-1RJ U-IRII P value Correlation 
Proportion 
Of cells (%) 2.4±0.6 10.9±1.3 P<0.001 R=0.53, 
p=O.005 
R/cell 461 +144 1468±396 P<0.001 R=0.39, 
p=O.013 
No significant correlation was found between GAG loss from 
cartilage and_expression of either IL-1RI or IL-1RII on chondro- 
cytes. 
Table 2. Relationship between GAG loss and IL-JR expression 
IL-1RI IL-IRII 
Proportion of cells (%) R-0.069, p=0.077 r=0.096, p=0.559 
R/cell R=0. 11, p=0.505 r=0.093, p=0.573 
Discussion: Significant regional differences in cartilage suscepti- 
bility to the effects of IL-I were found. However, the absence of 
any significant relationship between the IL-IR expression and IL- 
1b-induced GAG release from cartilage suggests that factors 
other than chondrocyte receptor expression influence the 
response of cartilage to the effects of this cytokine. 
Reference 
1. Webb et al., (1997) Osteoarthritis Cartilage, 5: 427. 
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Aim: To assess the effects of two antioxidants, N-monomethyl-L- 
arginine (LNMMA) and N-acetylcysteine (NAC) on the expression 
of TGF-~I, 132 and 133 and their receptors I and il, using LPS-treat- 
ed human chondrocytes. 
Methods: Human chondrocytes were treated for 48h with LPS 
(10 Zg/ml), L-NMMA (0.5 mM) or NAC (1 mM). Nitrite levels were 
assayed using the Griess method. The expression of NO syn- 
thase (iNOS), TGF-131, 132, 133, TGF-13-.RI and II, was determined 
by semi-quantitative RT-PCR. 
Results: LPS induced a dramatic increase of both NO and iNOS 
mRNA levels. L-NMMA abolished NO production without affect- 
ing iNOS mRNA levels. In contrast, NAC strongly synergized with 
LPS to stimulate NO synthesis. LPS did not significantly alter 
TGF-I31 expression whereas L-NMMA inhibited its production. 
TGF-132 mRNA level was decreased by LPS and was not changed 
by L-NMMA. On the other hand, NAC counteracted the LPS- 
induced inhibition of TGF-b2 expression. TGF-b3 mRNA level 
was markedly reduced by LPS alone, or with both LoNMMA and 
NAC. TGF-~RI expression was slightly increased by the combi- 
nation LPS+L-NMMA or LPS+NAC whereas that of TGF~-RII was 
reduced in these conditions. 
Conclusions: ROS differentially control the TGF-I] system, 
depending on the isoform: TGF-I31 mRNA level depends on NO 
whereas that of TGF-132 is regulated by ROS and TGF-133 seems 
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to be unaffected by both of them. The expression of TGF-~ 
receptors appeared to be modulated by the levels of NO and 
other ROS. 
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Aim: This study sought to examine the influence of IL-lt~ on the 
expression of transforming rowth fac~or-~ by cultured normal 
and dedifferentiated bovine chondrocytes. 
Methods: Steady-state levels of mRNA for TGF-~I and TGF-~2 
were determined by Northern blotting. TGF-13 protein production 
was analyzed by ELISA in cell culture supematants. Transient 
transfection of TGF-131 promoter constructs was performed to 
characterize the DNA sequences which mediate the IL-- 1effect. 
Results: Primary bovine chondrocytes treated by IL- 16 in low 
serum level (2%) showed a significant increase in TGF-131 expres- 
sion, whereas TGF-~2 production was reduced. In high concen- 
tration of serum (10%), IL-IJ3 induced an inhibitory effect on TGF- 
t31 expression over the first 48 h and a stimulation at 72 h. TGF- 
~2 reduction was still observed in the presence of 10% serum. 
The 11_-1 effect on TGF-~I expression was abolished in cells ded- 
ifferentiated by repeated culture passages whereas TGF-~2 was 
also reduced. A 80-pb sequence of the TGF-~I promoter (-732/- 
652) was found to mediate the IL-1 effect on this gene. 
Conclusions: TGF-~I, because of its specific promoter structure, 
can be increased by IL-Ib in articular chondrocytes. This suggests 
that IL-1, besides its deleterious effect on cartilage, could initiate 
the repair response observed in early stages of OA through its 
ability to enhance local TGF-131 expression by chondrocytes. 
in CIA mice which was a RA model. 
4: Direct interaction of chondrocyte with autologous T cell: 
Chondrocytes from articular cartilage were co-cultured with 
autologous T cells and the response was evaluated as prolifera- 
tion by 3H-uptake. The response was exclusively higher in OA 
chondrocytes and this reaction was inhibited by anti-HLA class I 
and II, CD4, CD8 antibodies. OA chondrocytes expressed HLA 
DP, DQ and DR molecules as well as CD80 and CD86. 
5: Chemokines in OA cartilage: CC chemokines (MCP-1 
RANTES, MIP-lc~, MIP-I~) were expressed in chondrocytes and 
some of them stimulated MMP-3 production and inhibited matrix 
synthesis. 
Conclusions: Taken together, we have revealed the presence of 
a wide spectrum of immunological responses in the pathogene- 
sis of OA and contribution of chondrocytes. Specific modulation 
of such responses may become a novel therapeutic approaches 
in OA. 
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Aim: Osteoarthritis (OA) has been considered as a degenerative 
joint disorder, however inflammatory cells infiltrated in the syn- 
ovial tissue of OA and IL-1, one of pro-inflammatory c tokines, 
was considered as a key molecule in the pathogenesis of OA. 
This series of work was performed to elucidate the immune 
mechanism in OA. 
Methods and Results: 
1: Clonal infiltration of T cells in the QA synovium: We examined 
the clonality of T cells infiltrating into the synovial tissues by the 
SSCP method on T cell receptors (TCRs), and consequently, 
some dominant T cell clones were detected. We further analyzed 
the structure of TCR ~ chain and revealed that some TCRs were 
common in the different samples. 
2 Autoantibodies against cartilage related proteins:YKL-39 (close- 
ly related to HC gp-3 9), and CILP(cartilage intermediate layer 
protein) were considered to be candidates of autoantigens. About 
10% of OA patients had autoantibody against these proteins. 
3: Arthritogenicity of YKL -40 and C/LP: Mice were immunized 
with YKL-40 and CILP fusion proteins, then, developed oligo 
arthritis. The number of affected joint and severity was less than 
